BrasilAgro - Brazilian Agricultural Real Estate Co: Form 20-F for the period ended Jun 30, 2020
Filed with the SEC on Oct 30, 2020 and accepted by EDGAR at Oct 30, 2020, 12:48 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2019-07-01 to 2020-06-30 | BRL 487.6m | ifrs-full:Revenue |
| Cost of revenue | 12 months2019-07-01 to 2020-06-30 | BRL 483.8m | ifrs-full:CostOfSales |
| Operating income | 12 months2019-07-01 to 2020-06-30 | BRL 164.3m | ifrs-full:ProfitLossFromOperatingActivities |
| Interest expense | 12 months2019-07-01 to 2020-06-30 | BRL 25.2m | us-gaap:InterestExpense |
| Diluted EPS | 12 months2019-07-01 to 2020-06-30 | BRL 2.09 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months2019-07-01 to 2020-06-30 | BRL 2.11 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months2019-07-01 to 2020-06-30 | BRL 69.0m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Cash and equivalents | At period end2020-06-30 | BRL 171.0m | ifrs-full:CashAndCashEquivalents |
| Current assets | At period end2020-06-30 | BRL 616.6m | ifrs-full:CurrentAssets |
| Total assets | At period end2020-06-30 | BRL 2.04bn | ifrs-full:Assets |
| Current liabilities | At period end2020-06-30 | BRL 400.1m | ifrs-full:CurrentLiabilities |
| Total liabilities | At period end2020-06-30 | BRL 922.8m | ifrs-full:Liabilities |
| Shareholders' equity | At period end2020-06-30 | BRL 1.12bn | ifrs-full:Equity |
| Shares outstanding | At period end2020-06-30 | 62,104,301 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001213900-20-034148. Last ingested by Listed: Oct 30, 2026, 11:05 ET. Listed shows no prices and gives no investment advice.